References
- Ercan S, Sari I, Ozer O, Yuce M, Davutoglu V. Huge left atrial appendage thrombus in a patient with atrial fibrillation: Successful treatment with tirofiban. Platelets. 2013;24(4):333–334
- Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, et al. ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2011;123(10):e269–e367
- Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369–2429
- Yuce M, Davutoglu V, Sari I, Cakici M, Ercan S. Complete thrombus resolution with tirofiban in obstructive mechanical prosthetic mitral valve thrombosis. Platelets. 2010;21(5):386–388
- Caceres-Loriga F, Santos-Gracia J. Use of glycoprotein IIb/IIIa receptor antagonist in prosthetic valve thrombosis. Platelets. 2010;21(7):583
- Yuce M, Davutoglu V, Sari I, Ozer O. Atrial septal defect occluder device huge thrombus in patient with low ejection fraction. Echocardiography 2010;27:E96–E97